TriLink BioTechnologies (TriLink®), a Maravai® LifeSciences company (NASDAQ: MRVI) and global provider of life science ...

TriLink BioTechnologies (TriLink®), a Maravai® LifeSciences company (NASDAQ: MRVI) and global provider of life science ...

TriLink BioTechnologies, a Maravai LifeSciences (MRVI) company and global provider of life science reagents and services, has signed a ...

TriLink BioTechnologies, a Maravai LifeSciences company (MRVI), has partnered with, Avantor (AVTR) to expand availability of its innovative ...

TriLink BioTechnologies, a Maravai LifeSciences company and provider of life science reagents and services, has partnered ...

Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech ...

The acquisition will expand Maravai and TriLink BioTechnologies' ability to enable customers to develop next-generation mRNA and CRISPR nucleic acid-based therapies. “Molecular Assemblies is the ...

Marvai LifeSciences has acquired assets and intellectual property from Molecular Assemblies at undisclosed terms. Marvai, a San Diego company, said Tuesday that the acquisition would expand the ...

This acquisition is set to enhance the capabilities of Maravai's subsidiary, TriLink BioTechnologies, particularly in the field of mRNA and CRISPR nucleic acid-based therapies manufacturing.

It looks like 2025 will be a revolutionary year for INFINOX. The CFD Broker is prepared to continue its remarkable 2024 with even greater expansion, innovation, and trust-building initiatives. The ...

NexGen Health in San Jose introduces Niagen Plus IV Therapy, an advanced treatment that boosts cellular health, enhances energy, and combats aging by replenishing NAD+ levels using nicotinamide ...

Molecular Assemblies proprietary Fully Enzymatic Synthesis TM technology to enhance mRNA and oligonucleotide manufacturing capabilities within the TriLink BioTechnologies business SAN DIEGO--(BUSINESS ...